Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$8.51 - $13.6 $336,527 - $537,812
39,545 Added 19012.02%
39,753 $417,000
Q2 2022

Aug 15, 2022

SELL
$7.31 - $11.85 $4,415 - $7,157
-604 Reduced 74.38%
208 $2,000
Q1 2022

May 13, 2022

SELL
$7.35 - $10.63 $837 - $1,211
-114 Reduced 12.31%
812 $7,000
Q4 2021

Feb 14, 2022

BUY
$4.19 - $9.56 $3,879 - $8,852
926 New
926 $9,000
Q3 2021

Nov 15, 2021

SELL
$3.56 - $4.64 $3.04 Million - $3.96 Million
-853,099 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$3.95 - $5.41 $952,321 - $1.3 Million
-241,094 Reduced 22.03%
853,099 $3.69 Million
Q3 2020

Nov 12, 2020

BUY
$8.56 - $26.93 $6.13 Million - $19.3 Million
716,039 Added 189.35%
1,094,193 $9.91 Million
Q2 2020

Aug 13, 2020

BUY
$21.21 - $31.55 $2.23 Million - $3.31 Million
105,054 Added 38.47%
378,154 $10.4 Million
Q3 2019

Nov 14, 2019

SELL
$29.87 - $42.22 $44,595 - $63,034
-1,493 Reduced 0.54%
273,100 $8.43 Million
Q2 2019

Aug 14, 2019

SELL
$31.16 - $39.46 $5.25 Million - $6.65 Million
-168,507 Reduced 38.03%
274,593 $10.8 Million
Q1 2019

May 10, 2019

BUY
$19.96 - $38.62 $702,592 - $1.36 Million
35,200 Added 8.63%
443,100 $17.1 Million
Q4 2018

Feb 13, 2019

BUY
$23.57 - $32.33 $775,453 - $1.06 Million
32,900 Added 8.77%
407,900 $9.62 Million
Q2 2018

Aug 10, 2018

BUY
$26.0 - $29.9 $9.75 Million - $11.2 Million
375,000 New
375,000 $11.2 Million

Others Institutions Holding TCDA

About Tricida, Inc.


  • Ticker TCDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,668,900
  • Market Cap $557K
  • Description
  • Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...
More about TCDA
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.